NUVECTIS PHARMA INC's ticker is and the CUSIP is 67080T108. A total of 14 filers reported holding NUVECTIS PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BALDWIN BROTHERS LLC/MA | 143,800 | $1,885,218 | 0.16% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 24,570 | $322,113 | 0.01% |
Man Group plc | 12,840 | $168,332 | 0.00% |
BANK OF AMERICA CORP /DE/ | 164 | $2,150 | 0.00% |
WELLS FARGO & COMPANY/MN | 25 | $328 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 35,022 | $459,138 | 0.00% |
STATE STREET CORP | 13,400 | $175,674 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 24,667 | $323 | 0.00% |
MORGAN STANLEY | 3,115 | $40,838 | 0.00% |